Augmenting Treatment of Obsessive-Compulsive Disorder with Antonovsky's Sense of Coherence Theory

Perspectives in Psychiatric Care

Volumn 39, Issue 4, 2003, Pages 163-168

  Joachim, Beverly ^a   Lyon, Debra D ^b   Farrell, S P ^b  

^a Psychiatry   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antonovsky's sense of coherence theory; Cognitive behavioral therapy; Neural behavioral habituation; Obsessive compulsive disorder

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CLINICAL FEATURE; COGNITIVE THERAPY; HUMAN; HUMAN RELATION; MENTAL HEALTH CARE; METHODOLOGY; NURSING; OBSESSIVE COMPULSIVE DISORDER; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; STANDARD; THEORY;

EID: 0742304635     PISSN: 00315990     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2003.00163.x     Document Type: Review

References (31)

1. Antonovsky, A. (1987a). Unraveling the mystery of health. San Francisco: Jossey-Bass.
2. Antonovsky, A. (1987b). Pathways leading to successful coping and health. In A. Antonovsky (Ed.), Unraveling the mystery of health: How people manage stress and stay well (pp. 31-63). San Francisco: Jossey-Bass.
3. Baxter, L.R., Schwartz, J.M., Bergman, K.S., Szuba, M.P., Guze, B.H., & Mazziotta, J.C. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry, 49, 681-689.
4. Bebbington, P. (1998). Epidemiology of obsessive-compulsive disorder. British Journal of Psychiatry, 35(Suppl.), 2-6.
5. Bruch, H. (1974). Learning psychotherapy. Cambridge, MA: Harvard University Press.
6. Freud, S. (1965). Interpretation of dreams (J. Strachey, Trans.) New York: Avon. (Original work published 1900)
7. Goodman, W.K. (1996). Neuropharmacology of obsessive-compulsive disorder. In M.A. Jenike (Ed.), Recent developments in neurobiology of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 57, 500-503.
8. Greist, J.H. (1998). The comparative effectiveness of treatments for obsessive-compulsive disorder. Bulletin of the Menninger Clinic, 62(4, Suppl. A), A65-A81.
9. Greist, J.H., Jefferson, J.W., Kobak, K.A., Katzelnick, D.J., & Serlin, R.C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Archives of General Psychiatry, 52, 53-60.
10. Hohagen, F., & Berger, M. (1998). New perspectives in research and treatment of obsessive-compulsive disorder. British Journal of Psychiatry, 173(Suppl. 35), 1.
11. Hollander, E., Kwon, J., & Stein, D. (1996). Obsessive-compulsive and spectrum disorders: Overview and quality of life issues. Journal of Clinical Psychiatry, 57(Suppl. 8), 3-6.
12. Hoogduin, C.A., & Hoogduin, W.A. (1984). The outpatient treatment of patients with an obsessive-compulsive disorder. Behavior Research Therapy, 22, 455-459.
13. Jenike, M.A., Rauch, S.I., Cummings, J.L., Savage, C.R., & Goodman, W.K. (1996). Recent developments in neurobiology of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 57, 492-503.
14. Kaplan, H.I., & Sadock, B.J. (1998). Synopsis of psychiatry: Behavioral sciences/clinical psychiatry. Philadelphia: Lippincott Williams & Wilkins.
15. Kelly, A. (1996). Selecting a serotonin reuptake inhibitor for obsessive-compulsive disorder. CNS Spectrums, 1(2), 32-38.
16. Lazarus, R.S. (1984). Puzzles in the study of daily hassles. Journal of Behavioral Medicine, 7, 375-389.
17. Leaman, T.L. (1999). Anxiety disorders. Primary Care Clinics in Office Practice, 26(2), 197-210.
18. Lego, S. (1992). Biological psychiatry and psychiatric nursing in America. Archives of Psychiatric Nursing, 6, 147-150.
19. March, J.S., Leonard, H.L., & Swedo, S.E. (1995). Neuropsychiatry of obsessive-compulsive disorder in children and adolescents. Comprehensive Therapy, 21, 507-512.
20. O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: A controlled study. Canadian Journal of Psychiatry, 44(1), 64-71.
21. Rauch, S.L., & Jenike, M.A. (1997). Neural mechanisms of obsessive-compulsive disorder. Current Review of Mood and Anxiety Disorders, 1, 84-94.
22. Rothenburg, A. (1998). Diagnosis of obsessive-compulsive illness. Psychiatric Clinics of North America, 21, 791-800.
23. Salkovskis, P.M., Forrester, E., & Richards, C. (1998). Cognitive-behavioral approach to understanding obsessional thinking. British Journal of Psychiatry, 173(Suppl. 35), 53-63.
24. Salkovskis, P., Shafran, R., Rachman, S., & Freeston, M. (1999). Multiple pathways to inflated responsibility beliefs in obsessional problems: Possible origins and implications for therapy and research. Behavior Research Therapy, 37, 1055-1072.
25. Schwartz, J.M. (1998). Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. British Journal of Psychiatry, 173(Suppl. 35), 38-44.
26. Shea, C.A., Pelletier, L.R., Poster, E.C., Stuart, G.W., & Verhey, M.P. (1999). Advanced practice nursing in psychiatric and mental health care. St. Louis: Mosby.
27. Shear, M.K. (1995). Psychotherapeutic issues in long-term treatment of anxiety disorder patients. Psychiatric Clinics of North America, 18, 885-893.
28. Stuart, G.W. (2001). Anxiety responses and anxiety disorders. In G.W. Stuart & M.T. Laraia (Eds.), Principles and practice of psychiatric nursing (7th ed.). St. Louis: Mosby.
29. Van Renyghe de Voxvrie, G. (1968). Use of anafranil (G 34586) in obsessive neuroses. ACTA Neurologica Belgica, 68, 787-792.
30. Wright, M., & Hewlett, W.A. (1994). Neurobiology of obsessive compulsive disorder. Comprehensive Therapy, 20(2), 95-100.
31. Zohar, J., Insel, T., & Rasmussen, S. (1991). The psychobiology of obsessive-compulsive disorder. New York: Springer.